Business Description
Biomea Fusion Inc
NAICS : 325412
SIC : 2834
ISIN : US09077A1060
Description
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 17.18 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -94.4 | |||||
| 3-Year EPS without NRI Growth Rate | -90.6 | |||||
| 3-Year FCF Growth Rate | -90.9 | |||||
| 3-Year Book Growth Rate | 191.8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.23 | |||||
| 9-Day RSI | 26.82 | |||||
| 14-Day RSI | 31.92 | |||||
| 6-1 Month Momentum % | 43.97 | |||||
| 12-1 Month Momentum % | -47.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.84 | |||||
| Quick Ratio | 7.84 | |||||
| Cash Ratio | 7.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.6 | |||||
| Shareholder Yield % | -2.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -74.7 | |||||
| ROA % | -64.03 | |||||
| ROIC % | -551.7 | |||||
| ROC (Joel Greenblatt) % | -806.51 | |||||
| ROCE % | -76.51 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.21 | |||||
| Price-to-Tangible-Book | 2.21 | |||||
| EV-to-EBIT | -1.74 | |||||
| EV-to-Forward-EBIT | -1.41 | |||||
| EV-to-EBITDA | -1.76 | |||||
| EV-to-Forward-EBITDA | -1.41 | |||||
| EV-to-Forward-Revenue | 76.72 | |||||
| EV-to-FCF | -2.2 | |||||
| Price-to-Net-Current-Asset-Value | 2.52 | |||||
| Price-to-Net-Cash | 2.56 | |||||
| Earnings Yield (Greenblatt) % | -57.47 | |||||
| FCF Yield % | -26.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BMEA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biomea Fusion Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.46 | ||
| Beta | -0.54 | ||
| Volatility % | 81.18 | ||
| 14-Day RSI | 31.92 | ||
| 14-Day ATR ($) | 1.058787 | ||
| 20-Day SMA ($) | 12.629 | ||
| 12-1 Month Momentum % | -47.07 | ||
| 52-Week Range ($) | 8.125 - 43.69 | ||
| Shares Outstanding (Mil) | 35.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biomea Fusion Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biomea Fusion Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biomea Fusion Inc Frequently Asked Questions
What is Biomea Fusion Inc(BMEA)'s stock price today?
The current price of BMEA is $10.45. The 52 week high of BMEA is $43.69 and 52 week low is $8.13.
When is next earnings date of Biomea Fusion Inc(BMEA)?
The next earnings date of Biomea Fusion Inc(BMEA) is 2024-05-02 Est..
Does Biomea Fusion Inc(BMEA) pay dividends? If so, how much?
Biomea Fusion Inc(BMEA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers